LONG-TERM PROLONGATION OF CARDIAC ALLOGRAFTS BY SUBTHERAPEUTIC LEVELS OF CYCLOSPORINE IN RATS CONDITIONED WITH PRETRANSPLANT BLOOD TRANSFUSIONS AND CYCLOSPORINE
- 1 January 1985
- journal article
- research article
- Vol. 39 (1) , 1-5
Abstract
This study was aimed at ascertaining whether long-term graft survival was achievable with short-term cyclosporine (CsA) therapy or with subtherapeutic doses of CsA in rats conditioned with blood transfusion (BT) combined with CsA. Previous studies had shown that donor-specific transfusions combined with a short course of CsA interacted synergistically, resulting in considerable prolongations of ACI and BUF grafts in LEW hosts receiving no postoperative treatment. The donor-specific depression of alloreactivity was confirmed by showing a depression of mixed-lymphocyte reaction (MLR) reactivity as well as of humoral antidonor responses in BT-CsA conditioned rats. The effects of postoperative CsA were then studied in recipients conditioned with BT-CsA or BT alone. ACI and BUF cardiac graft survival in LEW hosts conditioned with BT and treated with a 5 day postoperative course of CsA (20 mg/kg per day) were indistinguishable from graft survival in untransfused hosts (ACI: 35.6 .+-. 15.5 vs. 38.8 .+-. 7.4; BUF: 58.4 .+-. 39.8 vs. 48.0 .+-. 21.7) indicating no interaction between BT and CsA under these conditions. In contrasts, the effect of a postoperative 5 day course of CsA (10 mg/kg per day) was extended by conditioning the recipients with donor-specific BT and CsA (ACI: 41.7 .+-. 7.0 vs. 27.4 .+-. 11.6; P < 0.05). More remarkably, a 30 day course of subtherapeutic doses of CsA (2.5 mg/kg per day) resulted in long-term prolongation (> 100 days) of ACI grafts in a large proportion of hosts conditioned with donor-specific BT and CsA, while the majority of controls conditioned with nonspecific BT and CsA or CsA alone rejected their grafts within 3 wk (P < 0.01). The possible mechanisms of this phenomenon are discussed.This publication has 13 references indexed in Scilit:
- EFFECTS OF CYCLOSPORINE ON THE IMMUNE SYSTEM OF THE MOUSE II. CYCLOSPORINE INHIBITS THE EFFECTOR FUNCTION OF PRIMARY T HELPER CELLS, BUT NOT HELPER CELL PRIMINGTransplantation, 1983
- Cyclosporin A does not prevent expression of Tac antigen, a probable TCGF receptor molecule, on mitogen-stimulated human T cells.The Journal of Immunology, 1983
- CYCLOSPORIN A SPARES SELECTIVELY LYMPHOCYTES WITH DONOR-SPECIFIC SUPPRESSOR CHARACTERISTICSTransplantation, 1981
- PROLONGATION OF RENAL ALLOGRAFT SURVIVAL IN THE RAT BY PRETREATMENT WITH DONOR ANTIGEN AND CYCLOSPORIN ATransplantation, 1981
- Cyclosporin A mediates immunosuppression of primary cytotoxic T cell responses by impairing the release of interleukin 1 and interleukin 2European Journal of Immunology, 1981
- Effect of cyclosporin A on human lymphocyte responses in vitro. I. CsA allows for the expression of alloantigen-activated suppressor cells while preferentially inhibiting the induction of cytolytic effector lymphocytes in MLR.The Journal of Immunology, 1980
- Cyclosporin A and dexamethasone suppress T cell responses by selectively acting at distinct sites of the triggering process.The Journal of Immunology, 1980
- PROLONGATION OF HETEROTOPIC CARDIAC ALLOGRAFTS IN RATS BY CYCLOSPORIN-A1980
- CYCLOSPORIN A INITIALLY AS THE ONLY IMMUNOSUPPRESSANT IN 34 RECIPIENTS OF CADAVERIC ORGANS: 32 KIDNEYS, 2 PANCREASES, AND 2 LIVERSThe Lancet, 1979
- Biological effects of cyclosporin A: A new antilymphocytic agentInflammation Research, 1976